263 related articles for article (PubMed ID: 27443998)
1. Neuroimaging in Central Nervous System Lymphoma.
Nabavizadeh SA; Vossough A; Hajmomenian M; Assadsangabi R; Mohan S
Hematol Oncol Clin North Am; 2016 Aug; 30(4):799-821. PubMed ID: 27443998
[TBL] [Abstract][Full Text] [Related]
2. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
3. Atypical radiological findings of primary central nervous system lymphoma.
Lin X; Khan IRA; Seet YHC; Lee HY; Yu WY
Neuroradiology; 2020 Jun; 62(6):669-676. PubMed ID: 32077984
[TBL] [Abstract][Full Text] [Related]
4. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
Malikova H; Koubska E; Weichet J; Klener J; Rulseh A; Liscak R; Vojtech Z
Cancer Imaging; 2016 Nov; 16(1):40. PubMed ID: 27894359
[TBL] [Abstract][Full Text] [Related]
5. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
[TBL] [Abstract][Full Text] [Related]
6. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
Nguyen AV; Blears EE; Ross E; Lall RR; Ortega-Barnett J
Neurosurg Focus; 2018 Nov; 45(5):E5. PubMed ID: 30453459
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
8. Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis.
Ge J; Zuo C; Guan Y; Zhao G
Clin Nucl Med; 2016 Oct; 41(10):e436-8. PubMed ID: 27355853
[TBL] [Abstract][Full Text] [Related]
9. [Multifocal central nervous system lymphoma misdiagnosed as acute disseminated encephalomyelitis].
Bakulin IS; Stoyda NI; Askarova LS; Konovalov RN; Prokazova PR; Bormin AA; Polishchuk RV; Ryabinkina YV; Anufriev PL; Gulevskaya TS; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):95-102. PubMed ID: 30160675
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
11. Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma.
Ambady P; Szidonya L; Firkins J; James J; Johansson K; White T; Jezierski C; Doolittle ND; Neuwelt EA
Leuk Lymphoma; 2019 Feb; 60(2):515-518. PubMed ID: 30033836
[No Abstract] [Full Text] [Related]
12. From the ER to the OR: Initial Evaluation of Primary Central Nervous System Lymphoma.
Baskaran AB; Dixit KS; Sonabend AW; Horbinski CM; Abutalib SA; Lukas RV
Neurologist; 2023 May; 28(3):135-142. PubMed ID: 37027168
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging of primary central nervous system lymphoma in immunocompetent patients: comparison of recent and previous findings.
Adachi K; Yamaguchi F; Node Y; Kobayashi S; Takagi R; Teramoto A
J Nippon Med Sch; 2013; 80(3):174-83. PubMed ID: 23832401
[TBL] [Abstract][Full Text] [Related]
14. Low ADC in CNS Lymphoma.
Pyatigorskaya N; Galanaud D; Dormont D; Soussain C; Kas A
Clin Nucl Med; 2020 Jul; 45(7):545-546. PubMed ID: 32404710
[TBL] [Abstract][Full Text] [Related]
15. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients.
Shi X; Zhang X; Yi C; Wang X; Chen Z; Zhang B
Clin Nucl Med; 2013 Feb; 38(2):98-102. PubMed ID: 23334122
[TBL] [Abstract][Full Text] [Related]
16. Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population.
Wu Y; Wang Y; Sun X; Bai X; Qian J; Zhu H; Cui Q; Xing R; Chen Y; Liu Q; Guo J; Ji N; Sun S; Liu Y
BMC Neurol; 2019 Nov; 19(1):268. PubMed ID: 31684888
[TBL] [Abstract][Full Text] [Related]
17. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
[TBL] [Abstract][Full Text] [Related]
18. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Evaluation in Primary CNS Lymphoma.
Lukas RV; Riedell P; Horowitz PM; Pytel P; Kamson DO
Neurologist; 2018 Mar; 23(2):53-54. PubMed ID: 29494436
[TBL] [Abstract][Full Text] [Related]
20. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
